Full Description
The renewal of interest in peritoneal dialysis as a treatment modality for patients with end-stage renal disease was stimulated by the report of Po- povich and his colleagues in 1976 on the technique of CAPD. With the in- troduction of commercial dialysate-containing plastic bags, which mark- edly reduced the incidence of peritonitis, the use of CAPD as a primary treatment modality has increased significantly. At the present time, more than 12% of the patients undergoing dialysis in the United States are utiliz- ing CAPD; however, the use of CAPD among pediatric patients is con- siderably greater. The First International Symposium on CAPD in Children was orga- nized in order to gather together experts with experience in treating chil- dren undergoing CAPD in an attempt to exchange current information on the utilization of this emerging technique in children.
Since pediatric pa- tients comprise a small percentage of the CAPD population and since lim- ited data were available concerning specific methodology and complica- tions of CAPD in children, it was hoped that an international symposium would provide a forum for an exchange of experience that would ultimate- ly lead to better adaptation and increased utilization of this technique.
Contents
Cellular Abnormalities in Uremia.- A Comparison of Peritoneal Water and Solute Movement in Young and Older Children on CAPD.- Transperitoneal Movements of Solutes of Different Molecular Size in Children on CAPD.- CAPD in Children: Data from the European Dialysis and Transplant Association (EDTA) Registry.- Indications for CAPD and CCPD in Children.- Comparison of CAPD and CCPD in Children.- CAPD in Acute Renal Failure: Clinical Experience in Children.- Glucose Metabolism in Uremia: Effect of Hemodialysis and CAPD.- Lipoprotein Profiles in Plasma and Dialysate of Children on CAPD.- Protein Losses During Peritoneal Dialysis in Children.- Amino Acid Dialysis in Children on CAPD.- Dietary Survey in a Group of Children Treated with CAPD.- The Management of the Infant on CAPD.- Growth of the Patient on CAPD.- Thyrotropin-Releasing Hormone and Growth Hormone-Releasing Factor in the Evaluation of Hypophyseal Function in Children Undergoing CAPD.- Thyroid Function in Children on CAPD.- Somatostatin Secretion in Children on CAPD and CCPD.- Biochemical and Hormonal Abnormalities of Mineral Metabolism in Children on CAPD.- Aluminum-Containing Phosphate Binding Agents and Plasma Aluminum Levels in Children Undergoing CAPD: Preliminary Results with the Use of Calcium Carbonate.- Evolution of Renal Osteodystrophy and the Effect of High-Dose Calcitriol in Children Undergoing CAPD.- Renal Anemia in Children on CAPD.- Loss of Ultrafiltration and Peritoneal Membrane Alterations in Children on CAPD.- Sclerosing Peritonitis in Patients Treated by CAPD.- Five Years' Experience with CAPD/CCPD Catheters in Infants and Children.- Peritonitis in Children Undergoing CAPD Versus CCPD.- Pharmacokinetics of Various Antibiotics During CAPD.- Prevention and Treatment of Peritonitis in Children onCAPD.- The Importance of the CAPD Nurse in Dealing with Patient/Family Burnout.- Renal Transplantation in Children Treated by CAPD: A Report on a Cooperative Study.
